Effect of Modified Global Risk Classification on Prognosis at Patients Undergoing Bypass Surgery and Percutaneous Coronary Intervention with Multi-vessel Disease

dc.authoridDeniz, Ali/0000-0001-5539-2863
dc.contributor.authorKaypakli, Onur
dc.contributor.authorSahin, Durmus Yildiray
dc.contributor.authorDeniz, Ali
dc.contributor.authorAktas, Halil
dc.contributor.authorAkilli, Rabia Eker
dc.contributor.authorIcen, Yahya Kemal
dc.contributor.authorCaglayan, Caglar Emre
dc.date.accessioned2024-09-18T20:32:55Z
dc.date.available2024-09-18T20:32:55Z
dc.date.issued2018
dc.departmentHatay Mustafa Kemal Ãœniversitesien_US
dc.description.abstractObjective: The aim of this study was to compare mortality and myocardial infarction in patients with multi-vessel disease using Modified Global Risk Classification (mGRC). Methods: We divided 579 patients into low, intermediate risk with a high EuroSCORE (IE), intermediate risk with a high SYNTAX score (IS), and high Modified Global Risk groups. Patients were evaluated for death, myocardial infarction, cerebrovascular events, need for re intervention, and a primary endpoint, which denotes the occurrence of any one of the four events. Results: Comparing the bypass surgery and percutaneous coronary intervention groups using mGRC showed significantly better prognostic results in the bypass surgery patients for the rate of the occurrence of the myocardial infarction for the IS group (p=0.047). In terms of the primary endpoint, the EuroSCORE, SYNTAX score, and Global Risk Classification (GRC) were found to be independent risk factors in logistic regression analysis. The ability of GRC to discriminate for the 1-year mortality was found to be better than that of the EuroSCORE and SYNTAX score. Conclusion: With the evaluation of the EuroSCORE and SYNTAX score together, the modified GRC, which includes both anatomical and clinical risk factors, provides an additional benefit for predicting the prognosis and decision of treatment in patients with multi-vessel disease.en_US
dc.identifier.doi10.5152/EurJTher.2018.435
dc.identifier.endpage60en_US
dc.identifier.issn2564-7784
dc.identifier.issn2564-7040
dc.identifier.issue1en_US
dc.identifier.startpage54en_US
dc.identifier.urihttps://doi.org/10.5152/EurJTher.2018.435
dc.identifier.urihttps://hdl.handle.net/20.500.12483/11211
dc.identifier.volume24en_US
dc.identifier.wosWOS:000436145200010en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAves Press Ltden_US
dc.relation.ispartofEuropean Journal of Therapeuticsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectModified global risk scoreen_US
dc.subjectcoronary artery bypass surgeryen_US
dc.subjectpercutaneous transluminal coronary angioplastyen_US
dc.titleEffect of Modified Global Risk Classification on Prognosis at Patients Undergoing Bypass Surgery and Percutaneous Coronary Intervention with Multi-vessel Diseaseen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ N/A ]
Ä°sim:
Tam Metin / Full Text
Boyut:
211.57 KB
Biçim:
Adobe Portable Document Format